Squamous cell carcinoma in epidermolysis bullosa. Treatment with systemic chemotherapy
β Scribed by Steven R. Lentz; Robert J. Raish; Edward P. Orlowski; Jay M. Marion
- Publisher
- John Wiley and Sons
- Year
- 1990
- Tongue
- English
- Weight
- 249 KB
- Volume
- 66
- Category
- Article
- ISSN
- 0008-543X
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
## Abstract ## Background We have shown that rILβ2 administration in recurrent head and neck cancers induces a tumorβspecific Tβlymphocyte reactivity and tumor regression; in a pilot study we have shown a safe and effective administration of rIL2 after cisplatin + 5βfluorouracil. Longβterm results
## Abstract ## BACKGROUND The effects of multimodality treatment on the survival of patients with esophageal carcinoma are unclear. The authors performed a prospective, Phase II study to assess the longβterm results of chemotherapy plus radiotherapy (RT) on patients with esophageal squamous cell c
## Abstract ## Background. Treatment of head and neck squamous cell carcinoma (HNSCC) addresses the primary tumor and the lymphatic drainage. Modalities for the neck are neck dissection and/or radiation therapy. In most cases, the neck is treated by the modality that seems more appropriate for the
Perineural invasion is a feature associated with significantly poorer outcomes when present in cutaneous squamous cell carcinoma (CSCC). The incidence of this subset of CSCC continues to rise in the US, as does the confusion surrounding exactly how it should be managed. While management typically in